LIBTAYO(Lebrikizumab) Side Effects

Common side effects of LIBTAYO include fatigue, rash, and diarrhea, with more severe immune-related adverse events being possible.

Side Effects of LIBTAYO

The most common side effects of LIBTAYO (≥20% incidence) include fatigue, rash, and diarrhea, which are generally manageable. However, serious immune-mediated adverse reactions may occur, including pneumonitis, hepatitis, colitis, nephritis, and endocrine disorders. These reactions may require treatment modifications such as discontinuation or corticosteroid therapy. Infusion-related reactions are also reported, ranging from mild to severe. Monitoring for adverse effects is crucial, and treatment may need to be adjusted based on the severity of symptoms. Further information regarding rare or long-term side effects is not specified in the description.